Matthew Todd Reding

Title: The Innovations of Matthew Todd Reding

Introduction

Matthew Todd Reding is an accomplished inventor based in University City, MO (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of treatments for viral infections. With a total of two patents to his name, Reding's work has the potential to impact the lives of many individuals suffering from hepatitis C virus (HCV) infections.

Latest Patents

Reding's latest patents include innovative compounds aimed at inhibiting the HCV NS5B polymerase. The first patent details compounds, processes for their synthesis, and methods for the treatment and prevention of HCV infection. This invention provides novel compounds and pharmaceutical compositions that can be utilized in combating HCV. The second patent also focuses on inhibitors of HCV NS5B polymerase, presenting compounds of Formula I that are useful for treating viral infections and associated diseases, particularly those related to HCV.

Career Highlights

Throughout his career, Matthew Todd Reding has worked with notable companies, including Pharmacia & Upjohn Company. His experience in the pharmaceutical industry has equipped him with the knowledge and skills necessary to innovate in the field of viral infection treatments.

Collaborations

Reding has collaborated with esteemed colleagues such as Robert C. Kelly and Nancy Anne Wicnienski. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Matthew Todd Reding is a notable inventor whose work in developing treatments for hepatitis C virus infections showcases his dedication to improving public health. His innovative patents and collaborations highlight his significant contributions to the pharmaceutical industry.